RMTI Rockwell Medical Inc

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES                                                                                   
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940                       

1. Name and Address of Reporting Person * ELLISON RUSSELL H	2. Issuer Name and Ticker or Trading Symbol ROCKWELL MEDICAL, INC. [ RMTI ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) See Remarks
(Last)          (First)          (Middle) C/O ROCKWELL MEDICAL, INC., 411 HACKENSACK AVENUE, SUITE 501	3. Date of Earliest Transaction (MM/DD/YYYY) 4/17/2020
(Street) HACKENSACK, NJ 07601 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.45	4/17/2020		A		600000		(1)	4/17/2030	Common Stock	600000.0	$0	600000	D
Stock Option (Right to Buy)	$2.45	4/17/2020		A		600000		(2)	4/17/2030	Common Stock	600000.0	$0	600000	D

Explanation of Responses:
(1)	Stock options vest in three equal installments on the first, second and third anniversaries of April 17, 2020.
(2)	Stock options vest upon achievement of specified milestone events. Stock options are subject to stockholder approval of an increase in the share reserve under the Rockwell Medical, Inc. 2018 Long-Term Incentive Plan at the 2020 annual meeting of stockholders.

Remarks: President and Chief Executive Officer

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
ELLISON RUSSELL H C/O ROCKWELL MEDICAL, INC. 411 HACKENSACK AVENUE, SUITE 501 HACKENSACK, NJ 07601	X		See Remarks

Signatures
/s/ Michael G. Costello, Attorney-in-Fact for Russell H. Ellison		4/20/2020
**Signature of Reporting Person		Date